# Illicit Drug Use and Stroke: Cannabis Stroke Risk Assessment > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-stroke-risk-assessment-clinical-insights/ > **Published:** 2026-03-13T11:27:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:08:08-04:00 > **Clinical Summary:** Explore cannabis stroke risk assessment and its clinical importance for patient counseling and stroke prevention strategies. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologySafetyResearch[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) Why This Matters Clinicians should be aware that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) is associated with increased stroke risk, which necessitates screening patients about cannabis consumption during stroke risk assessments and counseling patients about this cardiovascular danger. Understanding this association helps practitioners contextualize sudden neurological symptoms in cannabis users and informs shared decision-making conversations about substance use [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/). Clinical Summary This study by Ritson and colleagues demonstrates that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), along with cocaine and amphetamine use, is associated with significantly increased odds of stroke in users. The research contributes to growing evidence that cannabis is not a benign substance and carries cardiovascular risks that clinicians should consider when evaluating stroke risk in patients, particularly younger individuals who may not have traditional vascular risk factors. The association between cannabis and stroke has important implications for [patient counseling](https://cedclinic.com/stroke-risk-assessment-substance-use/), risk stratification, and clinical decision-making around cannabis use in populations with existing cardiovascular disease or stroke risk factors. Understanding this relationship helps clinicians better inform patients about the potential cerebrovascular consequences of cannabis use and supports more comprehensive [risk assessment](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/) during initial and ongoing care. Clinicians should incorporate cannabis use history into stroke risk evaluation and discuss cardiovascular complications when counseling patients considering or actively using cannabis. Dr. Caplan’s Take “We need to separate the cannabis signal from stimulant-induced stroke risk in these studies, because the mechanisms are fundamentally different. Cannabis users in this population are often poly-substance users, and it’s the sympathomimetic drugs like cocaine and amphetamines that reliably cause acute hypertension and vasospasm, whereas cannabis’s cardiovascular effects are much more modest and idiosyncratic. The clinical takeaway for my patients is straightforward: if you have stroke risk factors, stimulants are far more dangerous than cannabis, but both warrant a careful conversation about your individual vascular health.” Clinical Perspective Clinicians should be aware that cannabis use joins cocaine and amphetamines as a substance associated with increased stroke risk, a finding that warrants inclusion in stroke [risk assessment](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/) and [patient counseling](https://cedclinic.com/stroke-risk-assessment-substance-use/). However, the association between cannabis and stroke remains incompletely understood, with potential confounders such as concurrent tobacco use, underlying cardiovascular disease, and the distinction between occasional and heavy use not always clearly delineated in available literature. The route of administration (smoking versus other methods), cannabis potency and cannabinoid profile, and individual genetic susceptibility may all modulate stroke risk in ways that current epidemiologic studies cannot fully capture. Given the increasing prevalence of cannabis use in many populations and its legal status in some jurisdictions, clinicians should routinely ask about cannabis consumption when taking vascular histories and counsel patients, particularly younger individuals, about this potential serious adverse effect. When discussing stroke prevention with cannabis users, individualized risk-benefit conversations that acknowledge both 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Illicit+drug+use+associated+with+increased+odds+of+stroke+-+Clinical+Trials+Arena+%40drcaplan&url=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fanalyst-comment%2Fillicit-drug-use-associated-increased-odds-stroke%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fanalyst-comment%2Fillicit-drug-use-associated-increased-odds-stroke%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Illicit+drug+use+associated+with+increased+odds+of+stroke+-+Clinical+Trials+Arena+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fanalyst-comment%2Fillicit-drug-use-associated-increased-odds-stroke%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - Recreational drugs can more than double risk of stroke, study suggests – The Guardian 📰 Source: [https://www.clinicaltrialsarena.com/analyst-comment/illicit-drug-use-associated-increased-odds-stroke/](https://www.clinicaltrialsarena.com/analyst-comment/illicit-drug-use-associated-increased-odds-stroke/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Recreational drugs like cocaine, cannabis increase stroke risk: Study – NewsBytes](https://cedclinic.com/cannabis-stroke-risk-counseling/) This article discusses how recreational drugs including cannabis contribute to increased stroke risk, providing important context for clinical assessments. [Read More](https://cedclinic.com/cannabis-stroke-risk-counseling/) [Recreational drugs can more than double risk of stroke, study suggests – The Guardian](https://cedclinic.com/cannabis-stroke-risk-clinical-evidence-stroke-prevention/) A detailed study highlighting the doubled stroke risk associated with recreational drug use, including cannabis, relevant for clinicians and patients. [Explore Study](https://cedclinic.com/cannabis-stroke-risk-clinical-evidence-stroke-prevention/) [Drug Use May Double Stroke Risk: Study Analysing 100 Million People Warns | GRAVITAS](https://cedclinic.com/recreational-drug-stroke-risk-study/) An extensive analysis revealing the doubled stroke risk from drug use, emphasizing the importance of comprehensive stroke risk assessments. [Learn More](https://cedclinic.com/recreational-drug-stroke-risk-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).